Patents-Review.com
🔗 Permalink
Assignee profile:

Infinity Discovery, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

18

Last publication date:

2013-08-08

Patent Grants:

17

Last grant date:

2014-04-22

Top Inventors for applications by Infinity Discovery, Inc.

These are the the leading inventors for applications assigned to Infinity Discovery, Inc.:

Recent patent applications by Infinity Discovery, Inc.

Infinity Discovery, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-08-08 ✅ Patent 8,703,755 granted on 2014-04-22
US20130203724A1
Human necessities

Analogs of benzoquinone-containing ansamycins and methods of use thereof

 #2 | 2013-05-23 ✅ Patent 8,609,706 granted on 2013-12-17
US20130131063A1
Chemistry; metallurgy

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

 #3 | 2012-04-05 ✅ Patent 8,431,566 granted on 2013-04-30
US20120083484A1
Chemistry; metallurgy

Cyclopamine lactam analogs and methods of use thereof

 #4 | 2012-03-15 ✅ Patent 8,426,436 granted on 2013-04-23
US20120065218A1
Chemistry; metallurgy

Heterocyclic cyclopamine analogs and methods of use thereof

 #5 | 2012-01-19 ✅ Patent 8,293,760 granted on 2012-10-23
US20120015934A1
Chemistry; metallurgy

Cyclopamine lactam analogs and methods of use thereof

 #6 | 2011-09-01 ✅ Patent 8,178,690 granted on 2012-05-15
US20110213145A1
Chemistry; metallurgy

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

 #7 | 2011-06-30 ✅ Patent 8,461,191 granted on 2013-06-11
US20110160259A1
Chemistry; metallurgy

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

 #8 | 2011-04-14 ✅ Patent 8,003,634 granted on 2011-08-23
US20110086110A1
Human necessities

Analogs of benzoquinone-containing ansamycins and methods of use thereof

 #9 | 2010-07-29 ✅ Patent 8,304,428 granted on 2012-11-06
US20100190791A1
Chemistry; metallurgy

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

 #10 | 2010-06-10 ✅ Patent 7,994,191 granted on 2011-08-09
US20100144775A1
Chemistry; metallurgy

Heterocyclic cyclopamine analogs and methods of use thereof

 #11 | 2010-04-22
US20100099116A1
Chemistry; metallurgy

Methods for Analysis of Hedgehog Pathway Inhibitors

 #12 | 2009-04-16 ✅ Patent 7,947,663 granted on 2011-05-24
US20090099131A1
Chemistry; metallurgy

Inhibitors of fatty acid amide hydrolase

 #13 | 2009-03-12 ✅ Patent 8,357,676 granted on 2013-01-22
US20090069281A1
Human necessities

Ansamycin formulations and methods of use thereof

 #14 | 2008-11-27 ✅ Patent 7,648,994 granted on 2010-01-19
US20080293755A1
Chemistry; metallurgy

Heterocyclic cyclopamine analogs and methods of use thereof

 #15 | 2008-11-20 ✅ Patent 7,964,590 granted on 2011-06-21
US20080287420A1
Chemistry; metallurgy

Cyclopamine lactam analogs and methods of use thereof

 #16 | 2008-10-30 ✅ Patent 7,875,628 granted on 2011-01-25
US20080269272A1
Chemistry; metallurgy

Cyclopamine analogues and methods of use thereof

 #17 | 2008-05-15 ✅ Patent 7,928,244 granted on 2011-04-19
US20080114167A1
Chemistry; metallurgy

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

 #18 | 2006-04-06 ✅ Patent 7,230,004 granted on 2007-06-12
US20060074030A1
Chemistry; metallurgy

Cyclopamine analogues and methods of use thereof
AssigneeID:

33860 ⎘